Clinical trial
A Study to Compare the Bioavailability of Two Sustained-release Theophylline Products
NCT02184247 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Compare the Bioavailability of Two Sustained-release Theophylline Products
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 1998
- Completion date
- Not reported
- Enrollment
- 22 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
healthy